ceralasertib,olaparib
astrazeneca,merck
['bcsm', 'ceralasertib', 'olaparib', 'tnbc', 'brca', 'plasmamatch']
#asco22 #plasmamatch #olaparib + #ceralasertib did not met efficacy endpoint in #tnbc
higher numerical reponse in pts with #brca mutations, atm loss and #rad51 low expression #senthildamodaran #bcsm 
Medonc at dpt of general medical oncology @UZleuven ????Knight to improve outcome of breast cancer pts ???? #TNBC #BCY #HereditaryCancerSyndromes